NSEOutcome of Board MeetingResults13 Aug 2026
Landsmill Green Limited
Outcome of Board Meeting
Landsmill Green Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, which will be published in newspapers and on the company's website. The trading window for dealing in securities will be opened after 48 hours of the meeting closed.
BSECompany Update▲ PositiveResults13 Aug 2026
Veefin Solutions Ltd
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Investor Presentation
Veefin Solutions Ltd has disclosed its Q1 FY27 financial performance, with standalone revenue and EBITDA increasing by 128.2% and 133.7% YoY respectively. The company reported a standalone EBITDA margin of 55.4% and a PAT of ₹6.74 Cr, with a PAT growth of 151.4% YoY. The company also highlighted its wins and multi-product traction, with 5 new clients, 6 products, and a single win of USD 15.27 Mn in Q1 FY27.
BSECompany Update13 Aug 2026
Max Healthcare Institute Ltd
Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Max Healthcare Institute Ltd has allotted 3,048 equity shares to eligible employees under the Employee Stock Option Scheme 2022, increasing the paid-up equity share capital to ₹973,27,64,860.
NSEESOP/ESOS/ESPSesop13 Aug 2026
Max Healthcare Institute Limited
ESOP/ESOS/ESPS
Max Healthcare Institute Limited has informed the Exchange regarding the allotment of 3,048 equity shares under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.
BSECompany Updateemployee_stock_option_scheme13 Aug 2026
Max Healthcare Institute Ltd
Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Max Healthcare Institute Ltd has granted 361,827 stock options to eligible employees under the Employee Stock Option Scheme 2022, with details provided in the annexure.
NSEESOP/ESOS/ESPSESG13 Aug 2026
Max Healthcare Institute Limited
ESOP/ESOS/ESPS
Max Healthcare Institute Limited has granted 361,827 stock options to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.
BSECompany Update▲ PositiveResults13 Aug 2026
SPML Infra Ltd
SPML Infra Ltd. Q1 FY 27 Revenue rises 74% to Rs. 86 Crore; PAT jumps 87% to 22.7 Crore
SPML Infra Ltd reported Q1 FY27 revenue of Rs. 3286 crore, up 74% YoY, with PAT increasing 87% to Rs. 22.7 crore. The company secured 31,293 crore of new orders and has an order book of approximately 35,094 crore.
BSENew Listingnew_listing13 Aug 2026
Solex Energy Ltd
Trading Members of the Exchange are hereby informed that effective from August 13, 2026, the Equity Shares of Solex Energy Ltd (Scrip Code: 544862) are listed and admitted to dealings ....
Solex Energy Ltd's equity shares have been listed and admitted to dealings on the BSE, effective August 13, 2026.
NSEPress Release▲ PositiveResults13 Aug 2026
SPML Infra Limited
Press Release
SPML Infra Limited has announced its Q1 FY27 financial results, reporting a 74% year-on-year growth in revenue to ₹286 crore, an 81% growth in EBITDA to ₹328 crore, and an 87% growth in PAT to ₹22.7 crore.
NSEAllotment of Securities13 Aug 2026
Cholamandalam Investment and Finance Company Limited
Allotment of Securities
Cholamandalam Investment and Finance Company Limited has informed the Exchange regarding allotment of 43,050 securities pursuant to ESOP/ESPS on August 12, 2026.
BSECompany Update13 Aug 2026
Cholamandalam Investment and Finance Company Ltd
Intimation on allotment of equity 43050 shares
Cholamandalam Investment and Finance Company Ltd has informed about the allotment of 43,050 equity shares to eligible employees on exercise of employee stock options.
BSENew Listingnew_listing13 Aug 2026
Swaraj Suiting Ltd
Trading Members of the Exchange are hereby informed that effective from August 13, 2026, the Equity Shares of Swaraj Suiting Ltd (Scrip Code: 544861) are listed and admitted to dealings ....
Swaraj Suiting Ltd, a new listing on the BSE, has been admitted to dealings effective August 13, 2026, with the scrip code 544861.
BSENew Listingnew_listing13 Aug 2026
LAPL Automotive Ltd
Trading Members of the Exchange are hereby informed that effective from August 13, 2026, the Equity Shares of LAPL Automotive Ltd (Scrip Code: 544863) are listed and admitted to dealings ....
LAPL Automotive Ltd's equity shares are listed on the BSE, effective August 13, 2026, with scrip code 544863.
NSEInvestor PresentationResults13 Aug 2026
Natural Capsules Limited
Investor Presentation
Natural Capsules Limited has informed the Exchange about Investor Presentation, enclosing the copy of investor presentation in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30, 2026.
NSEPress Release▲ PositiveResults13 Aug 2026
Natural Capsules Limited
Press Release
Natural Capsules Limited has announced its financial results for the quarter ended June 30, 2026, with revenue of ₹4871 Cr, EBITDA of ₹1.12 Cr, and EBITDA margins of 2.30%. PAT was ₹5.74Cr, with a 15% increase YoY.
BSECompany UpdateResults13 Aug 2026
Natural Capsules Ltd
Please find enclosed herewith the copy of Investors Presentation in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30, 2026.
Natural Capsules Ltd has released its Q1FY27 financial results, showing revenue of ₹48.71 Cr, EBITDA of ₹1.12 Cr, and PAT of ₹-5.74 Cr. The company witnessed sustained demand across its capsule products and improved realisations, but faced challenges in the HPMC segment due to US market uncertainty and geopolitical issues in the APl business.
BSECompany UpdateResults13 Aug 2026
Natural Capsules Ltd
Please find enclosed herewith the copy of Press Release made to analysts and investors in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30, 2026.
Natural Capsules Ltd reported its Q1FY27 results, with revenue of ₹4871 Cr, EBITDA of ₹1.12 Cr, and EBITDA margins of 2.30%. The company witnessed sustained demand across its capsule products and improved realisations, but faced challenges in the HPMC segment due to uncertainty in the US market. The API business presented a mixed picture, with ongoing geopolitical uncertainty and headwinds from the depreciation of the Indian rupee.
NSEGeneral UpdatesMgmt Change13 Aug 2026
Shalimar Paints Limited
General Updates
Shalimar Paints Limited has informed the Exchange about the change in authorization of key managerial personnel for determining materiality of an event or information and disclosure to Stock Exchanges.
BSECompany UpdateMgmt Change13 Aug 2026
Shalimar Paints Ltd-$
PFA disclosure under Reg 30(5) of SEBI LODR, 2015
Shalimar Paints Ltd has disclosed a change in authorization of key managerial personnel for determining materiality of an event or information and disclosure to stock exchanges, as per Regulation 30(5) of SEBI LODR, 2015. The Board of Directors has authorized Mr. Kuldip Raina, Mr. Kundan Sangwar, and Ms. Snehal Saboo to determine materiality of events or information and make necessary disclosures to stock exchanges.
NSEAppointmentMgmt Change13 Aug 2026
Shalimar Paints Limited
Appointment
Shalimar Paints Limited has appointed Mr. Kundan Sangwar as Chief Financial Officer (CFO) of the company, effective August 12, 2026. The company also approved the appointment of a new CFO, increase in authorized share capital, addition of non-cumulative non-participating compulsorily convertible preference shares, and proposals for raising funds through various means.